胰岛素免疫测定:了解检测对象——两种新免疫测定的评估
研究评估两种新胰岛素免疫测定与五种成熟测定对十种商业胰岛素(人胰岛素及类似物)的交叉反应性,并检测糖尿病或胰腺移植患者血样。结果显示不同免疫测定对胰岛素类似物的特异性存在差异,可分为识别所有类型胰岛素、仅识别人胰岛素及识别比例可变三类。准确解读胰岛素血症需了解所用免疫测定的特异性。
要点
- 不同免疫测定对胰岛素类似物的识别能力存在差异。
- 非特异性测定可识别所有类型胰岛素,特异性测定仅识别人胰岛素。
- 解读胰岛素结果需了解所用免疫测定的特异性。
核心结论
- 准确解读胰岛素血症依赖于了解所用免疫测定的特异性。
研究设计与样本
- 比较两种新胰岛素免疫测定与五种成熟免疫测定对十种商业胰岛素的反应性。
- 检测已知治疗的糖尿病或胰腺移植患者血样中的胰岛素。
主要发现
- 与重组人胰岛素不同,免疫测定对胰岛素类似物的特异性存在差异。
- 免疫测定可分为三类:识别所有类型胰岛素(BI-INS-IRMA®、Architect®、Access®)、仅识别人胰岛素(Cobas®)、识别人胰岛素和类似物但比例可变(Liaison XL®、iFlash®、Maglumi®)。
临床怎么用
- 解读胰岛素血症结果时需考虑免疫测定对胰岛素类似物的特异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insulin is essential for glycemic regulation but diseases can cause a default or an excess of insulin secretion leading to dysregulated glycemia. Hence, measurement of insulinemia is useful to investigate hypoglycemia, determine the pathogenesis of diabetes and evaluate β-cell function. Thus, diabetic patients need supplementation with recombinant human insulin and/or insulin analogues. Analogues have primary sequences different from native human insulin and may not be detected by some immunoassays. The objective of our study was to evaluate new insulin immunoassays by determining their ability to detect different types of human insulin or analogues. METHODS: This study compared the reactivity of two new insulin immunoassays with five well-established immunoassays on ten commercial insulins. We also measured insulin in blood samples from diabetic or pancreas transplant patients with known treatment. RESULTS: Contrary to recombinant human insulin, there were differences in the specificity to insulin analogues. We distinguished three immunoassay categories: those recognizing all types of insulin such as the non-specific BI-INS-IRMA®, Architect® and Access® immunoassays; those recognizing human insulin only (Cobas®); and those recognizing human insulin and analogues in variable proportions (Liaison XL®, iFlash® and Maglumi®). CONCLUSION: An accurate biological interpretation of insulinemia relies on knowledge of the specificity of the immunoassay used.
引用
- Violin A, Enard E, Blin J, et al. Insulin: Know what your immunoassay detects. Evaluation of two new immunoassays. Clin Chim Acta. 2023. PMID: 37598742. doi:10.1016/j.cca.2023.117516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。